Menu
GeneBe

2-147899762-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_001616.5(ACVR2A):c.392C>G(p.Thr131Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

ACVR2A
NM_001616.5 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.26
Variant links:
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, ACVR2A
BP4
Computational evidence support a benign effect (MetaRNN=0.24097243).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACVR2ANM_001616.5 linkuse as main transcriptc.392C>G p.Thr131Arg missense_variant 4/11 ENST00000241416.12
ACVR2ANM_001278579.2 linkuse as main transcriptc.392C>G p.Thr131Arg missense_variant 5/12
ACVR2ANM_001278580.2 linkuse as main transcriptc.68C>G p.Thr23Arg missense_variant 4/11
ACVR2AXM_047446292.1 linkuse as main transcriptc.68C>G p.Thr23Arg missense_variant 4/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACVR2AENST00000241416.12 linkuse as main transcriptc.392C>G p.Thr131Arg missense_variant 4/111 NM_001616.5 P1P27037-1
ENST00000402410.2 linkuse as main transcriptn.211-160G>C intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 21, 2022The c.392C>G (p.T131R) alteration is located in exon 4 (coding exon 4) of the ACVR2A gene. This alteration results from a C to G substitution at nucleotide position 392, causing the threonine (T) at amino acid position 131 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.0075
T
BayesDel_noAF
Benign
-0.25
Cadd
Benign
23
Dann
Benign
0.93
DEOGEN2
Benign
0.29
T;.;T
Eigen
Benign
0.020
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.24
T;T;T
MetaSVM
Benign
-0.47
T
MutationAssessor
Benign
1.4
L;.;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.0
N;N;N
REVEL
Benign
0.21
Sift
Benign
0.45
T;T;T
Sift4G
Benign
0.52
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.39
MutPred
0.28
Loss of glycosylation at T131 (P = 0.0011);.;Loss of glycosylation at T131 (P = 0.0011);
MVP
0.66
MPC
1.0
ClinPred
0.90
D
GERP RS
5.3
Varity_R
0.18
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-148657331; API